Immunovant (IMVT) had the highest return between October 1, 2022 and October 30, 2022 by a mid-cap US stock, returning 95.1%.
| ASSET | DATE | % RETURN |
|---|---|---|
Immunovant (IMVT) | 10/1/2022 - 10/30/2022 | 95.06% |
Nuvalent (NUVL) | 10/1/2022 - 10/30/2022 | 80.67% |
Vaxcyte (PCVX) | 10/1/2022 - 10/30/2022 | 76.98% |
Spyre Therapeutics (SYRE) | 10/1/2022 - 10/30/2022 | 73.58% |
Avis Budget (CAR) | 10/1/2022 - 10/30/2022 | 58.83% |
Oceaneering International (OII) | 10/1/2022 - 10/30/2022 | 57.96% |
Viking Therapeutics (VKTX) | 10/1/2022 - 10/30/2022 | 50.72% |
Tidewater (TDW) | 10/1/2022 - 10/30/2022 | 45.87% |
Impinj (PI) | 10/1/2022 - 10/30/2022 | 44.94% |
Norwegian Cruise Line (NCLH) | 10/1/2022 - 10/30/2022 | 43.03% |
CommScope (COMM) | 10/1/2022 - 10/30/2022 | 42.92% |
Sylvamo (SLVM) | 10/1/2022 - 10/30/2022 | 39.9% |
Enerpac Tool (EPAC) | 10/1/2022 - 10/30/2022 | 39.62% |
Patterson-UTI Energy (PTEN) | 10/1/2022 - 10/30/2022 | 39.31% |
Transocean (RIG) | 10/1/2022 - 10/30/2022 | 39.23% |
Gap (GAP) | 10/1/2022 - 10/30/2022 | 36.63% |
Caesars Entertainment (CZR) | 10/1/2022 - 10/30/2022 | 36.62% |
Par Pacific (PARR) | 10/1/2022 - 10/30/2022 | 35.46% |
Modine Manufacturing (MOD) | 10/1/2022 - 10/30/2022 | 35.24% |
Bel Fuse B (BELFB) | 10/1/2022 - 10/30/2022 | 34.93% |
Olema Pharmaceuticals (OLMA) | 10/1/2022 - 10/30/2022 | 34.42% |
Kymera Therapeutics (KYMR) | 10/1/2022 - 10/30/2022 | 34.3% |
Extreme Networks (EXTR) | 10/1/2022 - 10/30/2022 | 34.29% |
Jackson Financial (JXN) | 10/1/2022 - 10/30/2022 | 34.13% |
Dana (DAN) | 10/1/2022 - 10/30/2022 | 34.08% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
